JP is a Principal at DPI, an Africa focused emerging market PE fund with US$1.8bn AuM, which he joined in 2016. He looks after 10 portfolio companies in sectors such as banking, higher education, pharmaceuticals, healthcare, agri-business, packaging, fintech and facilities management. He is a Board member of the HPM Hospital in Marrakech, a 220-bed state of the art facility specialising in oncology, general surgery, orthopaedics and paediatrics. He was also involved in founding Kelix Bio, a US$750 million specialty generics emerging markets pharmaceutical buy and build platform, focused on oncology and critical care drugs.
His prior work experience combines investment banking at BNP Paribas and JPMorgan with management consulting at McKinsey & Company and The Boston Consulting Group. He has extensive experience leading M&A, strategy and transformational projects for government entities, major corporations and financial sponsors across both developed markets (North America, Europe) and emerging markets (Africa, Middle East, South East Asia). JP has worked and lived in 5 continents and visited over 125 countries.
JP speaks 5 languages and graduated from Imperial College London with a Masters in Aeronautical Engineering. JP is a citizen of France, Canada and Bangladesh.